An announcement would be appropriate to inform investors re outcome of these discussions whether positive or negative.Cheers
ASX/Media Release
Monday 11th May 2009
PRIMA BIOMED TO COMMENCE DISCUSSIONS WITH POTENTIAL NORTH
AMERICAN INVESTMENT PARTNERS
Australian health care company Prima BioMed (Prima) (ASX: PRR) is pleased to
announce that it will commence discussions with potential major North American
institutional investment funds later this month for the development of its core product,
the CVac™ ovarian cancer therapy vaccine.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.7M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.0¢ | 26.0¢ | $1.129M | 4.264M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 31426 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 37000 | 1 |
View Market Depth
| Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |